Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition

Gastroenterology

Volumn 138, Issue 1, 2010, Pages 347-359

  Kluwe, Johannes ^a   Pradere, Jean Philippe ^a   Gwak, Geum Youn ^a   Mencin, Ali ^a   De Minicis, Samuele ^b   Österreicher, Christoph H ^a   Colmenero, Jordi ^b   Bataller, Ramon ^b,c   Schwabe, Robert F ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CARBON TETRACHLORIDE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE MODEL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROGENESIS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; MYOFIBROBLAST; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 72249114470     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.09.015     Document Type: Article

References (43)

1. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
2. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134 (2008) 1655-1669
3. Minden A., and Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333 (1997) F85-F104
4. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr Opin Cell Biol 19 (2007) 142-149
5. Hibi M., Lin A., Smeal T., et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7 (1993) 2135-2148
6. Bogoyevitch M.A., and Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 70 (2006) 1061-1095
7. Schwabe R.F., Bradham C.A., Uehara T., et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37 (2003) 824-832
8. Hui L., Zatloukal K., Scheuch H., et al. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 down-regulation. J Clin Invest 118 (2008) 3943-3953
9. Maeda S., Chang L., Li Z.W., et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNF-α. Immunity 19 (2003) 725-737
10. Schwabe R.F., Uchinami H., Qian T., et al. Differential requirement for c-Jun NH2-terminal kinase in TNF-α- and Fas-mediated apoptosis in hepatocytes. FASEB J 18 (2004) 720-722
11. Wang Y., Singh R., Lefkowitch J.H., et al. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 281 (2006) 15258-15267
12. Uehara T., Bennett B., Sakata S.T., et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42 (2005) 850-859
13. Gunawan B.K., Liu Z.X., Han D., et al. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131 (2006) 165-178
14. Henderson N.C., Pollock K.J., Frew J., et al. Critical role of c-Jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 56 (2007) 982-990
15. Singh R., Wang Y., Xiang Y., et al. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49 (2009) 87-96
16. Sakurai T., Maeda S., Chang L., et al. Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 103 (2006) 10544-10551
17. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88 (2008) 125-172
18. Bataller R., Schwabe R.F., Choi Y.H., et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112 (2003) 1383-1394
19. Yoshida K., Matsuzaki K., Mori S., et al. Transforming growth factor-β and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 166 (2005) 1029-1039
20. Schnabl B., Bradham C.A., Bennett B.L., et al. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 34 (2001) 953-963
21. Oakley F., Meso M., Iredale J.P., et al. Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 128 (2005) 108-120
22. Dietrich N., Thastrup J., Holmberg C., et al. JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ 11 (2004) 301-313
23. Magness S.T., Bataller R., Yang L., et al. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40 (2004) 1151-1159
24. Seki E., De Minicis S., Osterreicher C.H., et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 13 (2007) 1324-1332
25. Schwabe R.F., Bataller R., and Brenner D.A. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285 (2003) G949-G958
26. Colmenero J., Bataller R., Sancho-Bru P., et al. Effects of losartan on hepatic expression of non-phagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am J Physiol Gastrointest Liver Physiol (2009) [Epub ahead of print]
27. Oakley F., Teoh V., Ching-A-Sue G., et al. Angiotensin II stimulation of RelA Serine 536 phosphorylation (P-Ser536-RelA) promotes myofibroblast survival and liver fibrosis. Gastroenterology 137 (2009) 2334-2344
28. Schwabe R.F., and Sakurai H. IKKβ phosphorylates p65 at S468 in transactivaton domain 2. FASEB J 19 (2005) 1758-1760
29. Svegliati-Baroni G., Ridolfi F., Caradonna Z., et al. Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J Hepatol 39 (2003) 528-537
30. Toivola D.M., Ku N.O., Resurreccion E.Z., et al. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 40 (2004) 459-466
31. Javelaud D., Laboureau J., Gabison E., et al. Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem 278 (2003) 24624-24628
32. Bosch M., Serras F., Martin-Blanco E., et al. JNK signaling pathway required for wound healing in regenerating Drosophila wing imaginal discs. Dev Biol 280 (2005) 73-86
33. Mattila J., Omelyanchuk L., Kyttala S., et al. Role of Jun N-terminal kinase (JNK) signaling in the wound healing and regeneration of a Drosophila melanogaster wing imaginal disc. Int J Dev Biol 49 (2005) 391-399
34. Sabapathy K., Hochedlinger K., Nam S.Y., et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15 (2004) 713-725
35. Khimji A.K., Shao R., and Rockey D.C. Divergent transforming growth factor-β signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation. Am J Pathol 173 (2008) 716-727
36. Kodama Y., Kisseleva T., Iwaisako K., et al. JNK1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137 (2009) 1467-1477
37. Schattenberg J.M., Singh R., Wang Y., et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 (2006) 163-172
38. Smart D.E., Green K., Oakley F., et al. JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation. Hepatology 44 (2006) 1432-1440
39. Alcorn J.F., van der Velden J., Brown A.L., et al. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 40 (2009) 422-432
40. Alcorn J.F., Guala A.S., van der Velden J., et al. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1. J Cell Sci 121 (2008) 1036-1045
41. Taura K., Miura K., Kodama Y., et al. Hepatocytes do not undergo epithelial mesenchymal transition during CCl4-induced liver fibrosis in mice. Hepatology 48 (2008) 381A
42. Ma F.Y., Flanc R.S., Tesch G.H., et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 18 (2007) 472-484
43. Wamsley-Davis A., Padda R., Truong L.D., et al. AT1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan. Am J Physiol Renal Physiol 287 (2004) F474-F480